PLUS THERAPEUTICS, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for PSTV, updated each market day.
PSTV AI Sentiment
AI predicts PLUS THERAPEUTICS, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: July 1, 2025
Subscribers see precise scores, buy/sell targets, and full analytics.
About PLUS THERAPEUTICS, Inc. Common Stock
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, commercializing and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
Sector
Exchange
Market Cap
$26,899,145
Cap Tier
Employees
28
Headquarters
AUSTIN, TX
Listed Since
Nov. 16, 2000
Website
PSTV Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
PSTV Volatility
PLUS THERAPEUTICS, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
